mizoribine has been researched along with methotrexate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fukao, K; Hamaguchi, H; Iwasaki, Y; Yuzawa, K | 1 |
| Demetris, AJ; Miyazawa, H; Murase, N; Nakamura, K; Starzl, TE; Tanabe, M; Valdivia, LA | 1 |
| Asano, G; Koda, M; Nakamura, H; Yoshino, S | 1 |
| Auzuki, A; Matsuoka, Y | 1 |
| Hara, M; Inoue, E; Kamatani, N; Kawaguchi, Y; Tanaka, E; Tomatsu, T; Yamanaka, H | 1 |
| Amano, H; Furuhata, N; Takasaki, Y; Tamura, N; Tokano, Y | 1 |
| Mimori, T | 1 |
| Ide, H; Isozaki, T; Kasama, T; Matsunawa, M; Miwa, Y; Negishi, M; Odai, T; Wakabayashi, K; Yajima, N | 1 |
| Kawashima, M; Kimoto, O; Mukai, T; Ogawa, N; Ohashi, H; Sawada, J; Shimoyama, K; Suzuki, D; Yamamura, M | 1 |
| Fujishiro, M; Hayakawa, K; Hirai, T; Ikeda, K; Morimoto, S; Nozawa, K; Ogawa, H; Sekigawa, I; Suzuki, S; Takamori, K; Takasaki, Y; Tamura, N; Tsushima, H; Yamaguchi, A | 1 |
| Hirai, T; Ikeda, K; Miyashita, T; Morimoto, S; Nakajima, S; Ogawa, H; Sekigawa, I; Takamori, K; Takasaki, Y; Tanji, K; Uomori, K; Watanabe, K | 1 |
| Sakai, N; Wada, T | 1 |
3 review(s) available for mizoribine and methotrexate
| Article | Year |
|---|---|
[Current treatment of collagen diseases. 4. Immunosuppressive agents: key points in their application].
Topics: Azathioprine; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Ribonucleosides | 1997 |
Hypocomplementemic urticarial vasculitis with Jaccoud's arthropathy and valvular heart disease: case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents; Complement System Proteins; Drug Therapy, Combination; Female; Finger Joint; Hand Deformities, Acquired; Histamine Antagonists; Humans; Immunosuppressive Agents; Joint Diseases; Methotrexate; Mitral Valve Insufficiency; Prednisolone; Radiography; Ribonucleosides; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous | 2008 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
3 trial(s) available for mizoribine and methotrexate
| Article | Year |
|---|---|
Acceptability and usefulness of mizoribine in the management of rheumatoid arthritis in methotrexate-refractory patients and elderly patients, based on analysis of data from a large-scale observational cohort study.
Topics: Age Factors; Aged; Arthritis, Rheumatoid; Cohort Studies; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prospective Studies; Ribonucleosides; Treatment Outcome | 2006 |
Effects of low-dose mizoribine pulse therapy in combination with methotrexate in rheumatoid arthritis patients with an insufficient response to methotrexate.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; C-Reactive Protein; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Health Status; Humans; Joints; Male; Matrix Metalloproteinase 3; Methotrexate; Middle Aged; Prospective Studies; Ribonucleosides; Severity of Illness Index; Surveys and Questionnaires | 2009 |
[Efficacy and safety of combination therapy with mizoribine and methotrexate for rheumatoid arthritis resistant with methotrexate].
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Ribonucleosides; Treatment Outcome | 2011 |
8 other study(ies) available for mizoribine and methotrexate
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Mutagenicity of cyclosporine against human cells.
Topics: Cells, Cultured; Cyclosporins; Humans; Immunosuppressive Agents; Lymphocytes; Mercaptopurine; Methotrexate; Mutagenicity Tests; Mutagens; Ribonucleosides; Sister Chromatid Exchange | 1987 |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
Topics: Animals; Antibodies; Antineoplastic Agents; Azathioprine; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Methotrexate; Mycophenolic Acid; Rats; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Heterologous | 1993 |
[Effects of disease modifying antirheumatic drugs (DMARDs) and DEX on IL-1 beta and IL-6 production by IL-1 beta stimulated synovial culture cells].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Cells, Cultured; Cysteine; Depression, Chemical; Dexamethasone; Gold Sodium Thiomalate; Humans; Interleukin-1; Interleukin-6; Methotrexate; Ribonucleosides; Sulfasalazine; Synovial Membrane; Tumor Necrosis Factor-alpha | 1996 |
The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone Resorption; Cathepsin K; Cell Differentiation; Drug Therapy, Combination; Female; Humans; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Methotrexate; Middle Aged; Osteoclasts; Prospective Studies; Real-Time Polymerase Chain Reaction; Ribonucleosides; Severity of Illness Index; Tacrolimus | 2017 |
Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Matrix Metalloproteinase 3; Methotrexate; Middle Aged; Pilot Projects; Ribonucleosides; Treatment Outcome | 2017 |
[Immunosuppressants-induced kidney injury].
Topics: Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Ribonucleosides; TOR Serine-Threonine Kinases | 2016 |